The Group is a biomedical enterprise listed on the Growth Enterprise Market (GEM) of The Stock Exchange of Hong Kong Limited. It integrates high-end medical device research and development, precision manufacturing, and biotechnology services, with a long-term focus on the fields of assisted reproduction and reproductive health. The Group is committed to enhancing clinical value and public health standards through technological innovation.
We possess a professional R&D team with an international perspective and have established long-term cooperative relationships with numerous leading hospitals and medical institutions, forming a complete translational system of “Research – Clinical – Product – Market”. Leveraging a mature portfolio of commercialized in vitro diagnostic reagent products, the Group has built a high level of trust within the procurement systems of medical institutions and has ranked among the top three major manufacturers in the mainland China market for male infertility in vitro diagnostic reagents. In addition, the Group was recognized as a “National High-Tech Enterprise” in 2011.
In terms of its technological pathway, the Group takes its independently developed traditional Chinese medicine enzyme transformation technology as the core, integrating modern enzyme-based science and technology to establish a unique full-cycle health management system of “Prevention – Conditioning – Treatment” expanding application scenarios in precision medicine and personalized health management.
The Group’s Canada-originated scientific research and industrial platform integrates R&D and production standards with a global vision, driving upgrades in product and service quality within the reproductive health sector.
Looking ahead, the Group will continue to invest in the research and development of biotechnology products, actively introduce advanced international technologies, and expand its business layout along the industrial chain, creating sustainable value in life sciences and health for society through outstanding scientific research capabilities
